Celcuity Inc.
CELC- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- SEC CIK
- 0001603454
In the last 90 days, Celcuity Inc. insiders filed 0 open-market purchases and 1 sale; 273 institutions reported holding it in 13F filings for Q2 2026, worth $5.95B in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in Celcuity Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 30
- −10 vs. Q2 2022
- Shares held
- 4.80M
- +857.4K (+21.7%) vs. Q2 2022
- Total value
- $48.2M
- +$12.3M (+34.3%) vs. Q2 2022
- New holders
- 1
- 5 more added
- Sold out
- 11
- 11 more reduced
1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CELC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 273 | $5.95B |
| Q1 2026 | 276 | $5.58B |
| Q4 2025 | 237 | $4.81B |
| Q3 2025 | 176 | $1.93B |
| Q2 2025 | 96 | $422.6M |
| Q1 2025 | 95 | $312.5M |
| Q4 2024 | 104 | $397.0M |
| Q3 2024 | 105 | $446.9M |
| Q2 2024 | 93 | $480.4M |
| Q1 2024 | 79 | $479.2M |
| Q4 2023 | 59 | $232.5M |
| Q3 2023 | 57 | $160.8M |
| Q2 2023 | 56 | $152.6M |
| Q1 2023 | 41 | $124.0M |
| Q4 2022 | 39 | $156.8M |
| Q3 2022 | 30 | $48.2M |
| Q2 2022 | 41 | $42.5M |
| Q1 2022 | 53 | $47.9M |
| Q4 2021 | 53 | $71.3M |
| Q3 2021 | 62 | $102.4M |
| Q2 2021 | 66 | $155.6M |
| Q1 2021 | 40 | $46.2M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Celcuity Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ellevest, Inc. | 6 | $0 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 156 | $1.57K | 0.00% | −759−83.0% | Reduced |
| US Bancorp | 548 | $6.00K | 0.00% | 00.0% | Unchanged |
| Tradition Wealth Management, LLC | 2,000 | $20.0K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 2,252 | $23.0K | 0.00% | +2,245+32,071.4% | Added |
| UBS Group AG | 4,335 | $44.0K | 0.00% | −977−18.4% | Reduced |
| Advisor Group Holdings, Inc. | 4,540 | $45.0K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 7,252 | $73.0K | 0.00% | +20.0% | Added |
| Murphy Pohlad Asset Management LLC | 11,200 | $112.0K | 0.05% | 00.0% | Unchanged |
| Cresset Asset Management, LLC | 13,223 | $133.0K | 0.00% | 00.0% | Unchanged |
| SNS Financial Group, LLC | 13,593 | $136.0K | 0.02% | 00.0% | Unchanged |
| Accredited Investors Inc. | 29,115 | $292.0K | 0.03% | 00.0% | Unchanged |
| State Street Corp | 31,380 | $315.0K | 0.00% | 00.0% | Unchanged |
| JNBA Financial Advisors | 38,091 | $382.0K | 0.06% | 00.0% | Unchanged |
| Northern Trust Corp | 39,413 | $395.0K | 0.00% | −1,620−3.9% | Reduced |
| BlackRock Inc. | 47,408 | $477.0K | 0.00% | −1,744−3.5% | Reduced |
| Bleichroeder LP | 50,000 | $502.0K | 0.10% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 56,556 | $568.0K | 0.00% | −29,200−34.1% | Reduced |
| Punch & Associates Investment Management, Inc. | 60,000 | $602.0K | 0.04% | 00.0% | Unchanged |
| Wells Fargo & Company | 69,016 | $692.0K | 0.00% | −45,533−39.7% | Reduced |
| Geode Capital Management, LLC | 71,096 | $713.0K | 0.00% | −14,015−16.5% | Reduced |
| Gagnon Securities LLC | 81,653 | $820.0K | 0.18% | −227,829−73.6% | Reduced |
| Jacob Asset Management of New York LLC | 98,049 | $984.0K | 1.07% | −18,000−15.5% | Reduced |
| PFM Health Sciences, LP | 140,426 | $1.41M | 0.05% | +140,426 | New |
| Vanguard Group Inc | 442,345 | $4.44M | 0.00% | −1,000−0.2% | Reduced |
| Soleus Capital Management, L.P. | 443,912 | $4.46M | 0.61% | +25,000+6.0% | Added |
| Millennium Management LLC | 453,356 | $4.55M | 0.01% | −55,891−11.0% | Reduced |
| Captrust Financial Advisors | 633,189 | $6.36M | 0.04% | +628,189+12,563.8% | Added |
| Commodore Capital LP | 920,464 | $9.24M | 1.49% | 00.0% | Unchanged |
| Morgan Stanley | 1,035,842 | $10.4M | 0.00% | +771,918+292.5% | Added |
| Gagnon Advisors, LLC | 0 | $0 | 0.00% | −181,353−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −46,954−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −28,115−100.0% | Sold out |
| Corton Capital Inc. | 0 | $0 | 0.00% | −22,560−100.0% | Sold out |
| Delphia (USA) Inc. | 0 | $0 | 0.00% | −21,312−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −13,202−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −126−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −79−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −86−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −35−100.0% | Sold out |
| Credit Suisse AG | 0 | $0 | 0.00% | −5−100.0% | Sold out |
| Frontier Wealth Management LLC | – | – | – | – | Not filed |